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The  purpose  of  this  paper  was  to  quantify  technical  and  economic  performance  of genetic  modiﬁcation
(GM)  applications  in  the  Dutch  pork  production  chain.  In total,  seven  GM applications  were  considered:
two  with  respect  to  the  pig itself,  i.e.,  ‘bovine  gene’  and  ‘enviropig’,  two  regarding  feed,  i.e., ‘GM crops’
and  ‘low  phytate  plants’,  and  three  with  regard  to feed additives  and  medicines.  The latter  included
‘antibodies’,  ‘microbial  phytase’  and  ‘immunocastration’.  A partial  budgeting  model  with  farrowing  and
fattening  stages  was  used  to estimate  the  impact  of  GM  applications  on  cost  prices  of a 25-kg piglet  and
1 kg  of pork  produced.  Overall,  the  production  of pork  with  GM  applications  was  found  to  be  cheaper  thanenetically modiﬁed pig
enetically modiﬁed additives and
edicines
artial budgeting
in the default  (no-GM)  situation.  Reductions  of  cost  prices  ranged  from  0.3%  to  3.7% in the  farrowing  stage
and  from  0.2%  to 2.2%  in the  fattening  stage.  Figures  were  found  to  be  rather  robust  as sensitivity  analyses
with  more  moderate  GM impacts  still  led  to cost  price  reductions  for the majority  of  GM  applications
considered.  The  results  may  contribute  to impact  assessments  of  GM  policies  in a European  production
environment.
 Roya© 2012
. Introduction
Genetic modiﬁcation (GM) is an emerging technology used
n the areas of food and feed production [1–3]. It is believed
hat genetic modiﬁcation has a great potential [4–6] as it can
ffer a wide range of beneﬁts to producers, consumers and
ociety. For example, producers may  proﬁt from an enhanced
rowth performance of animals and from reduced production
osts, e.g., animal health, feeding and manure costs [6]. As for
he consumers, beneﬁts may  be found in an increased quality of
eat (less fat, fewer residues) and lower prices [7]. Additionally,
ociety as a whole may  beneﬁt from a reduced environmental
mpact (reduction in quantity of waste and its changed com-
osition with regard to minerals) and improved animal welfare
8].
In general, consumers in Europe are rather sceptical about
enetic modiﬁcation and products produced by means of it [9–11].
et, previous research has shown that not all consumers react
imilarly to GM products [12–16]. Consumers are willing to con-
ider purchasing GM products if these products have special
eneﬁts. For example, in France, 42% of the consumers were
illing to buy products made with GM if these products were
sufﬁciently inexpensive’ [12]. Also, about 21% of a sample of
rish consumers was found to accept GM yoghurt that offered
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various consumer beneﬁts [15]. Similarly, in their study in the
Netherlands, Novoselova et al. [13] demonstrated that 29.3% of
the participants would buy GM pork produced with different GM
applications with clear beneﬁts. Meuwissen et al. [16] found that
12% of Dutch pork consumers could be entitled as ‘economists’
not attaching much importance to issues of GM at the feed-
ing and breeding level, as long as the pork was sufﬁciently
cheap.
In this framework there might be a market for GM products. But
why would producers step into this uncertain market? Although
the possible beneﬁts of applying GM are recognized, only a few
studies translated these into economic consequences [6,17]. Our
study took the chain approach and quantiﬁed the expected impact
of various GM applications on cost prices in the chain. More specif-
ically, the purpose of this paper was to quantify technical and
economic performance of GM applications in pork production
chains (farrowing and fattening stages) in the Netherlands. All cal-
culations were made for a farrowing farm with 540 sow places and
a fattening farm with 3300 pig places and an occupation rate of
93%.
The paper is structured as follows. Section 2 presents the materi-
als and methods including the GM applications used in the analysis,
the set-up of the model, and the technical input values per stage.
Data collection methods are also presented in this section. Section
3 presents the results of the partial budgeting model for the default
situation and for situations in which a GM application was  used.
Also the results of the sensitivity analysis are presented here. The
last section outlines the conclusions and future outlook.
es. Published by Elsevier B.V. All rights reserved.
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Table  1
Applications of genetic modiﬁcation (GM) in pork production through pigs (GM pig),
feed  (GM feed) and feed additives and medicines (GM additives and medicines) and
potentially beneﬁting stakeholders.
Stakeholder GM pig GM feed GM additives and
medicines
Producer Bovine gene GM crops Antibodies
Society Enviropig Low phytate
plants
Microbial
phytase
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expected number of weaning days for the ‘bovine piglets’ was 26.5,Consumer Spinach gene Edible vaccines Immunocastration
a Not used in the analysis.
. Materials and methods
.1. GM applications and sub-applications in livestock production
hains
Following Novoselova et al. [13], three types of genetic mod-
ﬁcation were selected for the analysis to cover the farrowing
nd fattening stages, i.e., GM pig, GM feed, and GM additives and
edicines. GM pig refers to a pig with modiﬁed genes. GM feed rep-
esents feed/crops produced with gene technology. GM additives
nd medicines refer to additives (phytase, vitamins) and medicines
antibiotics, vaccines) produced with the help of genetic modiﬁ-
ation. Per GM application, three concrete sub-applications were
dentiﬁed (Table 1).
Sub-applications were grouped according to the expected
eneﬁciaries (producer, society, consumer). Regarding the sub-
pplications relevant to producers, these were ‘Bovine gene’ [18],
GM crops’ (GM soy and maize) [8,19] and ‘Antibodies’ [20–22].
hese sub-applications were expected to decrease production
osts by improving animal growth performance or reducing feed
osts. Sub-applications relevant to society were expected to reduce
he impact of pork production on the environment by lowering
he excretion of phosphorus in the manure. In this study these
ere ‘Enviropig’ [23], ‘Low phytate (LP) plants’, i.e., GM soy and
aize [24], and ‘Microbial phytase’ [24,25]. For the group of sub-
pplications important to consumers only the application aiming
t improving animal welfare (‘Immunocastration’) [26] was  consid-
red. For the two other ones, i.e., aiming at producing leaner meat
‘Spinach gene’) [27] and reducing the use of antibiotics (‘Edible
accines’) [28–30], not enough data were available.
.2. Data collection: technical and economic data
Data gathering on the technical and economic parameters of the
M applications under consideration took place in two  steps. First,
n extensive literature review was carried out in which we empha-
ized GM effects on pork production parameters such as average
rowth rate, feed conversion ratio and litter size. Moreover, from
he scientiﬁc results also possible ranges of expected effects were
erived (to be used later in the sensitivity analyses).
Literature mostly refers to USA and Canadian circumstances.
herefore, the second step was to discuss the applicability of lit-
rature ﬁndings to Dutch pork production circumstances. This was
one by face-to-face interviews with experts selected on the basis
f their ﬁeld of expertise: nutritionists, animal physiologists, ani-
al  breeders, plant breeders, veterinarians, and representatives of
he feed industry. Due to relatively limited experience in Europe
ith the majority of GM applications under consideration, values
rom literature were assumed to be applicable. For ‘Low phytate
lants’ and ‘Microbial phytase’, however, there was more practi-
al experience. So for these applications technical parameters and
xpected impacts for feed prices were ﬁne tuned to European cir-
umstances.rnal of Life Sciences 64– 65 (2013) 9– 15
2.3. Model: general outline
A partial budgeting model was  used. The model consisted of two
stages: farrowing and fattening. In the farrowing stage piglets were
kept until their live weight reached 25 kg, after which they were
transferred to the fattening stage. In the fattening stage, piglets
grew until a live weight of about 115 kg. Then the fattening pigs
were transported to the slaughterhouse. Optionally, the farrowing
and fattening stages can either be specialized as separate stages
(different farms) or be integrated into one stage (single farms). The
ﬁrst option was  assumed in this study.
In the model, three types of parameters were distinguished:
input parameters, output parameters and parameters that rep-
resent inter-stage relations. Input parameters were technical
parameters such as litter size and number of weaning days, and
economic parameters such as the price of feed per kg. In the default
scenario, parameter values were derived from analyses by the Ani-
mal  Science Group [31,32]. Output parameters were summarized
in cost categories and differed depending on the stage in the chain.
For the farrowing stage these included, amongst other, labour costs,
feed costs and health care costs (including medicines). For the fat-
tening stage these were, for instance, costs of purchasing piglets,
feed costs and costs of mortality. Total costs were presented per
animal, i.e., costs per sow per year (farrowing stage) and costs per
fattening pig delivered (fattening stage). The inter-stage parame-
ter used in this model is the cost price of 25-kg piglets sold for
fattening.
In the model we distinguished a default situation in which the
regular pork parameters were assumed [31,32] and a GM situation
in which one of the GM applications was applied. In the GM sit-
uation, input values generally reﬂected the average of GM effects
as described in literature. For two  parameters, however, experts
during the personal interviews indicated “to stay at the moderate
side”, i.e., for the impact of ‘GM crops’ on the prices of feed and
for the impact of ‘Immunocastration’ on the average daily gain of
fattening pigs.
2.4. Farrowing stage: default and GM applications
In the farrowing stage (Table 2), main parameters were number
of weaning and rearing days, litters and piglets per sow per year,
and piglet mortality (both pre- and post-weaning). In the default
situation the sow’s production cycle approximated 157 days. This
was based on a gestation period of 115 days, a lactation period
of 28 days and a 14-day interval between weaning and breeding.
Piglets were weaned at 28 days and then housed in separate rear-
ing pens. In these pens they were reared until a live weight of 25 kg
(about 70 days old). Of the 11.9 piglets born alive per litter, 12.1%
die before weaning and 1.9% die after weaning. Therefore, the num-
ber of piglets per sow per year was corrected according to these
mortality rates. Furthermore, it was  assumed that a total number
of 4307 working hours per year was  available [32]. The amount of
feed consumed per animal group (piglets, lactating sows, breed-
ing sows, boars) was taken according to the standard ration with
average net energy content [33]. So, for example, for a piglet a
total of 28.1 kg of feed was  required for the whole farrowing period
[32].
As for the GM situation, one or more input parameters can differ
from the default situation depending on the nature of the GM appli-
cation. For example, in the case of ‘Bovine gene’, a direct effect was
expected for the number of weaning days, i.e., the increased amount
of sow milk induced increased growth of piglets [18]. Therefore thewhich is 5.4% lower than in the default situation. Such a decrease
also affects the sow’s production cycle as well as the number of lit-
ters and piglets per sow per year. In addition, to produce extra milk
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Table  2
Major technical input values for farrowing stage in the default situation and in case of applications of genetic modiﬁcation (GM).
Variable Default GM applications
Bovine
gene
GM crops Antibodies Enviropig Low phytate
plants
Microbial
phytase
Immunocastration
Sow cycle (days) 157.0 155.5 150.0
Litter size (piglets) 11.9
Piglets’ mortality (%)
–  Pre-weaning 12.1
–  Post-weaning 1.9
Weaning at (days) 28.0 26.5 21.0
Delivering at (days) 70.0 68.3 63.0
Piglet weight (kg) 25
Litters per sow per year 2.33 2.39 2.43
Price feed (D per 100 kg)
– Piglets 28.50 28.24a
– Sow, boar 18.0 17.8
Inorganic P added to diet (kg) 3.18 0.48 2.83 1.39
P  excreted (kg) 7.68 4.98 7.32 5.89
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aTime  for castration (min per sow per year) 14.73 
a Prices include GM maize and GM soy.
 sow needs extra feed, which was estimated at 0.5 kg of feed per kg
f milk [33]. Also, given the better growth rate of ‘bovine piglets’, the
umber of rearing days was expected to decrease as well, which in
urn led to a reduced amount of piglet feed and medicines required.
‘GM crops’ were expected to only affect feed prices. For instance,
onsidering the amount of GM maize and GM soy in piglet feed,
ts price was expected to decrease from D 28.50 per 100 kg to D
8.24 per 100 kg. The ‘Antibodies’ application for piglets affected
he same technical input parameters as the ‘Bovine gene’: wean-
ng and rearing days, sow cycle and number of litters and piglets
er sow per year. In this case the effect, however, was  due to the
ntibodies that protect early-weaned piglets from diseases, in par-
icular E. coli [20–22]. The GM applications ‘Enviropig’, ‘LP plants’
nd ‘Microbial phytase’ inﬂuenced the amount of inorganic phos-
horus (P) supplemented to the diet and the amount of P excreted
n the manure [23–25]. These values decreased most in case of the
Enviropig’. With regard to ‘Immunocastration’, because no castra-
ion of piglets was required, less labour was needed in the farrowing
tage [26].
For all GM applications in the farrowing stage, including those
f ‘Bovine gene’ and ‘Enviropig’, we assumed prices for breeding
ows to be the same as in the default situation.
.5. Fattening stage: default and GM applications
At the starting live weight of 25 kg, piglets were transferred
o the fattening stage, where they stayed for approximately 120
ays, until a live weight of 115 kg was attained. An important
nput parameter at this stage was average daily growth rate (in
he default: 774 g per day), which was related to the feed conver-
ion ratio (in the default situation: 2.65 kg feed per kg gain). The
eed conversion ratio is the amount of feed per kg of live weight
ain. The number of deliveries per year is related to the average
aily growth rate, which implies that a higher number of deliveries
er year can be attained if the average daily growth rate increases.
he amount of feed for fattening pigs in the default and GM situa-
ions was calculated according to the standard ration with average
nergy content [33] (Table 3).
In the fattening stage, the ‘Bovine gene’ and ‘Antibodies’ applica-
ions did not have an effect on technical input values. In case of ‘GM
rops’, the same effects were expected as in the farrowing stage, i.e.,
ower prices for GM soy and maize ingredients in diets under con-
ideration. As for ‘Enviropig’, ‘LP plants’ and ‘Microbial phytase’,
mpacts were again expected through inorganic P-supplemented
nd P-excreted. With respect to ‘Immunocastration’, fattening pigs0
were vaccinated twice in the fattening stage, which involved
additional labour and GM vaccines. Due to the effects of ‘Immuno-
castration’, average daily gain and feed conversion ratio increased
by 2.6% and 2.5%, respectively.
3. Results
3.1. The default situation
The analysis of production costs in the farrowing and fatten-
ing stages resulted in a cost price of D 46.20 per piglet sold and
D 1.39 per kg of pork produced (Tables 4 and 5). Of the various
costs of production, feed was  the main component in the farrowing
stage, representing 36.9% of the total costs. In the fattening stage,
feed costs were the second most important cost component, rep-
resenting 34.2% of total costs. Major costs in this stage included
the purchase of 25-kg piglets (36.7% of total costs of production).
Tables 4 and 5 do not specify cost items that were not at all affected
by any of the GM applications, such as costs of housing and interest
payments.
3.2. Effects of GM applications on the economic performance of
pork production
In the ‘Bovine gene’ application, feed costs and healthcare costs
per sow per year decreased by D 4.00 and D 2.70, respectively,
because of the various effects described above. This leads to a
decrease of 1.3% in the cost price per piglet produced. In the fat-
tening stage, however, no further technical improvements were
expected and the reduced cost price (−0.4%) came directly from
the lower cost price of piglets. Amongst all GM applications, the
largest impact on the cost price in the farrowing stage was from
the ‘Antibodies’ application (−3.7%). This decrease was explained
by the decrease in weaning days (7 days) and, thus the increase in
piglets per sow per year (24.9 piglets). The resulting effect for the
fattening stage was a cost price reduction of 1.4% per kg of pork
produced.
In the case of ‘Enviropig’, ‘LP plants’ and ‘Microbial phytase’,
lower cost prices came from decreased feed costs (less inorganic
P was  supplemented to the feed) and savings on manure costs due
to less P excreted (a farm’s manure costs depend, amongst other,
on amount and type of minerals in the manure). Among these three
applications ‘Enviropig’ had the highest impact in both stages. With
this application, the cost price of piglets produced was D 45.03, i.e.,
2.5% lower than in the default situation. For pork this was D 1.36
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Table  3
Major technical input values for fattening stage in the default situation and in case of applications of genetic modiﬁcation (GM).
Variable Default GM applications
Bovine genea GM crops Antibodiesa Enviropig Low phytate
plants
Microbial
phytase
Immunocastration
Average daily gain (g per day) 774 794
Feed  conversion ratio 2.65 2.58
Mortality rate (%) 3
Number of deliveries per year 3.13 3.21
Feed  price (D per 100kg) 18.0 17.8b
Inorganic P added to diets (kg) 0.26 0.00 0.21 0.04
P  excreted (kg) 0.84 0.58 0.80 0.62
Price  vaccine (D per 2 pieces) 1.42 1.42
Twice  vaccination (min per pig) 0.54
a No technical effects are expected in this stage.
b Prices include GM maize and GM soy.
Table 4
Cost price (D ) per 25-kg piglet in the default situation and for applications of genetic modiﬁcation (GM).
Costs Default GM applications
Bovine gene GM crops Antibodies Enviropig Low phytate
plants
Microbial
phytase
Immunocastration
Cost per sow per year
Total labour 157.4 157.4 157.4 157.4 157.4 157.4 157.4 152.9
–  Castration −4.5a
Feed 406.1 402.1 402.3 414.6 405.3 406.0 405.5 406.1
Health 48.0 45.3 48.0 45.5 48.0 48.0 48.0 48.0
Otherb 169.5 169.5 169.5 169.5 143.2 166.0 152.1 169.5
–  Manure −26.4 −3.5 −17.5
Totalc 1100.9 1094.2 1097.0 1106.8 1073.6 1097.2 1080.2 1096.4
Cost  price per 25-kg piglet
D per piglet 46.2d 45.6 46.0 44.5 45.0 46.0 45.3 46.0
%  change 100 −1.3 −0.4 −3.7 −2.5 −0.3 −1.9 −0.4e
a A minus sign means a cost saving; for example, due to GM the costs saved on labour are D 4.5.
b Cost category ‘other’ includes water, heating, electricity, telephone, insurance, manure costs.
3.8.
p
t
c
c
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b
T
Cc Total costs also include costs of housing, interest and compulsory levies.
d Based on the number of piglets per sow per year; in the default this number is 2
e Per male piglet delivered.
er kg, i.e., 2.2% lower than the default value. The effect was mainly
he result of savings on manure costs. The second highest effect
ame from ‘Microbial phytase’. Because of lower feed and manure
osts in the farrowing stage, and lower manure costs (D 1.40) in the
attening stage, cost prices per piglet and per kg of pork decreased
y 1.9% and 1.8%, respectively. The application of ‘LP plants’ had the
able 5
ost price (D ) per kg pork in the default situation and for applications of genetic modiﬁca
Item Default GM applications
Bovine gene GM crops Antibodies 
Costs per hog delivered
Total labour 5.0 5.0 5.0 5.0 
–  Vaccination 
Piglet price 46.2 45.6 46.0 44.5 
Feed  costs 43.1 43.1 42.8 43.1 
Mortality 2.5 2.5 2.5 2.4 
Otherb 9.7 9.7 9.7 9.7 
–Vaccine  price 
–Manure 
Totald 125.9 125.4 125.4 124.2 
Costs  per kg pork
D per kg 1.393 1.387 1.387 1.374 
%  change 100 −0.4 −0.4 −1.4 
a A plus sign means that labour costs increased due to vaccination.
b Cost category ‘other’ includes water, heating, electricity, telephone, insurance, manur
c Plus and minus signs imply increase and decrease of costs, respectively, due to GM ap
d Total costs also include costs of housing, interest and compulsory levies.
e Per male fattening pig delivered.smallest impact on cost prices, also amongst all GM applications,
resulting in a 0.3% decrease in cost prices in both the farrowing and
fattening stages. This impact was  relatively limited because of the
limited use of GM soy and GM maize in European diets [34–36].
The same held for ‘GM crops’, which also included GM maize and
GM soy.
tion (GM).
Enviropig Low phytate
plants
Microbial
phytase
Immunocastration
5.0 5.0 5.0 5.2
+0.2a
45.0 46.0 45.3 46.0
43.1 43.1 43.1 42.0
2.4 2.5 2.5 2.5
8.0 9.4 8.3 11.1
+1.4c
−1.7c −0.3 −1.4
123.1 125.6 123.7 127.9
1.362 1.389 1.368 1.390
−2.2 −0.3 −1.8 −0.2e
e costs.
plications.
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Table  6
Results of sensitivity analyses in farrowing and fattening stage per application of genetic modiﬁcation (GM).
Farrowing Fattening
Default no-GM/most
likely GM (value)
Change in GM
parameters (%)
Impact on cost
pricea (%)
Default no-GM/most
likely GM (value)
Change in GM
parameters (%)
Impact on cost
pricea (%)
Bovine gene
Weaning days 28/26.5 −10/+10 −4.0/+3.0 n.a.b n.a. −1.4/+1.1
GM  crops
Feed price piglet 28.5/28.24 −1,−3/−3,−5c −0.4/−0.5 n.a. n.a. n.a.
Feed  price sow 18.0/17.8 −1,−3/−3,−5 18.0/17.8 −1,−3/−3,−5 −0.4/−0.6
Amount used 200/200 800d −1.0 200/200 800 −1.2
Antibodies
Weaning days 28/21 −14.0/+14.0 −5.4/−2.1 n.a. n.a. −2.1/−0.7
Enviropig
P  supplemented 3.18/0.48 −10/+10 −2.9/−2.0 0.26/0.00 −10/+10 −2.7/−1.8
Low  phytate plants
P supplemented 3.18/2.83 −10/+10 −1.0/+0.3 0.26/0.21 −10/+10 −0.5/+0.4
Microbial phytase
P  supplemented 3.18/1.39 −10/+10 −4.0/−1.4 0.26/0.04 −10/+10 −2.9/−1.3
Immunocastration
Average daily gain n.a. n.a. n.a. 774/794 +1.6/+3.6 −0.4/−0.7e
a Compared with default cost price in no-GM situation.
b n.a. = not applicable.
c The reduction in prices for GM crops; the comma  separates the reduction in prices for GM maize and GM soy.
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e Per male fattening pig delivered.
With regard to ‘Immunocastration’, the cost price per male
iglet delivered decreased by 0.4%, mainly due to savings on labour
osts. In the farrowing stage the labour costs decreased by D 4.50
er sow per year, because the farmer no longer needed to castrate
he piglets. However, in the fattening stage, ‘Immunocastration’
equired vaccination of the animals, which resulted in a slight
ncrease in labour costs. Moreover, the costs of vaccines increased
he total costs of production. ‘Immunocastration’ also increased the
verage daily gain of piglets by 2.6%, causing the number of deliv-
ries per year to rise from 3.13 (default) to 3.21 (+0.08) per year.
ecause daily gain was related to the feed conversion ratio, the
atter decreased from 2.65 (in the default) to 2.58. Totalling these
ffects, the cost price per male fattening pig delivered decreased by
.2% compared with the default.
Overall, the production of pork with GM applications was  found
o be cheaper than in the default (no-GM) situation. Reductions in
ost prices ranged from 0.3% to 3.7% in the farrowing stage and from
.2% to 2.2% in the fattening stage.
.3. Sensitivity analyses with regard to GM applications
The results of the sensitivity analyses for both stages are pre-
ented in Table 6. Analyses were based on percentages representing
easonable ranges for the impact of GM applications (input values)
n output parameters (cost prices). In Table 6, the default values
epresent the values of the input parameters in the no-GM and
most likely GM’  situations, as presented in Tables 2 and 3. Ranges
or changes in GM parameters were mostly in two  directions, indi-
ating higher and lower values. Only for the input parameters for
hich experts indicated to use moderate values in the most likely
ituation (price of feed, average daily gain) changes were in one
irection, i.e., lower feed prices and higher daily gains, respectively.
n the case of GM crops not only the prices for the crops can be
aried, but also the amount of GM crops in the diet. Although in
uropean diets wheat prevails over other cereals and particularly
ver the use of soy and maize [34–36], we increased the amounts
f maize and soy from approximately 20% (in the default) to 80%s of GM soy/maize per kg of feed.
in all diets used in the farrowing and fattening stages. Results were
compared with the default cost price in the no-GM situation.
In the farrowing stage, the highest impact of the sensitivity anal-
yses was found for the ‘Antibodies’, i.e., in case the application led
to a further reduction of the number of weaning days by 14%, the
cost price decreased by 5.4%. In the fattening stage, highest impacts
were for ‘Enviropig’ and ‘Microbial phytase’, i.e., a maximum reduc-
tion in cost prices of 2.7% and 2.9%, respectively. Sensitivity analyses
illustrated that for the majority of GM applications also the more
moderate input values led to cost price reductions in the fattening
and farrowing stages.
4. Conclusions and outlook
The objective of this paper was to assess the potential economic
impact of adopting GM technology on Dutch pig farms. To attain
this goal, a partial budgeting model for two production stages, i.e.,
farrowing and fattening, was  developed in which the impact of dif-
ferent GM applications could be analysed and compared with the
default situation.
From the results obtained it can be concluded that GM applica-
tions are expected to improve the economic performance of pork
production farms by reducing cost prices by 0.3–3.7% in the far-
rowing stage and by 0.2–2.2% in the fattening stage. Of all the GM
alternatives, ‘Antibodies’ is expected to have the largest effect in the
farrowing stage (3.7% cost price reduction), whereas ‘LP plants’ are
expected to have the lowest impact (0.3% cost price reduction). In
the fattening stage, the largest effect is expected from ‘Enviropig’
(2.2% cost price reduction per kg of pork) and the smallest from
‘Immunocastration’ (0.2% reduction). Generally, cost savings are
expected to be larger in the farrowing stage than in the fattening
stage. Sensitivity analyses show that maximum expected economic
gains are up to cost price reductions of around 5.5% and 3% in the
farrowing and the fattening stage, respectively.In interpreting these results it should be kept in mind that some
applications are still at laboratory level, such as with the ‘GM pig’.
Also, due to EU legislation and European consumers’ resistance
to GM technology and GM foods, there is still limited practical
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xperience in a European pork production framework. However,
esults of the sensitivity analyses demonstrate that conclusions are
ather robust as more moderate GM impacts still lead to cost price
eductions for the majority of GM applications under consideration.
For the farrowing farm (540 sows) and fattening farm (3300 pig
laces) that were studied, results show that gross margins would
nnually improve by about D 30,000 and D 50,000 at the maxi-
um,  respectively. At the individual farm level this seems to be a
ubstantial amount. However, whether it is sufﬁcient to actually
otivate farmers to introduce GM into their production practices
if allowed) is likely to depend also on other factors. For instance,
nalyses revealed that there is still some uncertainty about the
echnical performance of GM applications. Furthermore, there is
lso uncertainty about the reactions of consumers. If consumers
re only willing to buy GM pork if prices decline, gross margins of
armers may  eventually be negatively affected.
The current paper quantiﬁes technical and economic impacts of
M applications. However, to guide consumer and society discus-
ions, further research should also be directed towards quantifying
ther potential beneﬁts, such as with regard to food security, the
nvironment and animal welfare. For instance, Borlaug [39] argues
hat GM applications can signiﬁcantly contribute to feeding the
orld. In addition, in case of ‘Enviropig’, ‘LP plants’ and ‘Micro-
ial phytase’, reductions in the excretion of phosphorus into the
nvironment are expected to vary from 5% to 35% (this study) or
n some cases up to 75% [23] compared with current practices.
urthermore, immunocastration is considered a potential alterna-
ive for surgical castration of piglets, which causes pain and stress
n the animals. In the Netherlands in 2008, for example, farmers
ere urged to perform castration with local anesthesia. Also, Dutch
etailers stated to no longer sell fresh pork from conventionally
astrated pigs. Immunocastration can be a new animal-friendly
lternative to surgical castration. Insight into multi-criteria
eneﬁts potentially increases the (economic) impact of GM
pplications.
The partial economic analyses performed in this paper are likely
o be useful for policymakers for two reasons. First, they contribute
o impact assessments of costs and beneﬁts of GM restrictions
n a European production environment. Second, once GM would
e allowed, they enable to calculate the ﬁnancial room for chain
nvestment and incentive programmes.
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